Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment-Reference-Cited by-同舟云学术

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

Published:2016-08 Issue:2 Volume:215 Page:212.e1-212.e15
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Hildesheim Allan,Gonzalez Paula,Kreimer Aimee R.,Wacholder Sholom,Schussler John^ORCID,Rodriguez Ana C.,Porras Carolina,Schiffman Mark,Sidawy Mary,Schiller John T.,Lowy Douglas R.,Herrero Rolando,Cortés Bernal,González Paula,Herrero Roland,Jiménez Silvia E.,Porras Carolina,Rodríguez Ana Cecilia,Hildesheim Allan,Kreimer Aimée R.,Lowy Douglas R.,Schiffman Mark,Schiller John T.,Sherman Mark,Wacholder Sholom,Pinto Ligia,Kemp Troy,Sidawy Mary,Quint Wim,van Doorn Leen-Jan,Palefsky Joel M.,Darragh Teresa M.,Stoler Mark H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference17 articles.

1. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions;Kjaer;Cancer Prev Res,2009

2. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial;Lehtinen;Lancet Oncol,2012

3. Efficacy of the HPV-16/18 Vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 Vaccine Trial;Hildesheim;Vaccine,2014

4. Understanding and learning from the success of prophylactic human papillomavirus vaccines;Schiller;Nat Rev Microbiol,2012

5. L1-specific protection from tumor challenge elicited by HPV16 virus-like particles;De Bruijn;Virology,1998

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study;Vaccines;2024-08-23

2. Immunohistochemistry staining of Eag1 and p16/Ki-67 can help improve the management of patients with cervical intraepithelial Neoplasia after cold knife conversion;Diagnostic Pathology;2024-07-11

3. Therapeutic Role of HPV Vaccination on Benign HPV-induced Epithelial Proliferations in Immunocompetent and Immunocompromised Patients: Case Study and Review of the Literature;Open Forum Infectious Diseases;2024-06-28

4. A comprehensive bibliometric analysis (2000–2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer;Frontiers in Pharmacology;2024-05-10

5. Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts;Infectious Diseases and Therapy;2024-04-08